Enabling system-level double blinding in implantable device trials: implementation of a device-integrated framework for automated execution and feedback control
Xiaoyan Yan, Xuelu Zhu, Guoxin Zhou, Jiandong Tang, Lei Chen, Chen YaoBackground:
Effective double blinding in implantable device trials is challenged by invasive procedures, programmable interventions, and continuous operator–device feedback loops that create multiple unblinding pathways. Existing approaches rely on procedural and organizational strategies that cannot fully eliminate allocation awareness, particularly during repeated device programming interactions, leaving a critical gap: no widely adopted device-integrated solution embeds blinding controls directly within device control systems.We aimed to develop a generalizable device-integrated framework for system-level double blinding in implantable device trials that embeds allocation concealment directly within the device control system and enables automated, indistinguishable intervention execution.
Methods:
A three-layer framework was developed comprising: (1) an allocation-concealed control module, (2) an automated execution module, and (3) a feedback simulation module. The framework was implemented in a prospectively registered randomized controlled trial evaluating an implantable deep brain stimulation (DBS) system for drug addiction treatment, enrolling 60 participants randomized 2:1 to active stimulation or sham control.
Results:
The system operated without errors, crashes, or hardware malfunctions attributable to the blinding framework throughout all programming sessions. No emergency unblinding events or protocol deviations related to allocation awareness occurred. Operators followed identical interface workflows regardless of treatment assignment, and no operational patterns suggestive of allocation inference were observed. These findings provide indirect evidence of operational feasibility; formal blinding integrity metrics were not prospectively collected.
Conclusions:
The device-integrated framework shifts the blinding paradigm from behavioral compliance toward system-level enforcement, demonstrating operational feasibility in a real-world implantable device trial. The generalizable three-layer architecture may be adaptable across electrical stimulation, drug delivery, and energy-based device modalities after device-specific validation.